The current study investigated the levels of AD- and cognition-related molecular biomarkers and the neurophysiological mechanisms of visuospatial working memory impairment in ADFH individuals with ApoE-4 carriers to extend the body of research exploring the neuropsychological performance in such a group [24,25,26]. Here, APOE is linked to Alzheimer disease.